Minerva Neurosciences, Inc. announced the election of Jeryl Hilleman to the Board of Directors of the Company. Jeri brings a broad life sciences background to Minerva that includes high growth commercial biopharma, med-tech and data science companies, said William F. Doyle, Lead Independent Director of Minerva. Ms. Hilleman is presently Chief Financial Officer of Intersect ENT.